Ness Ziona, Israel, July  22, 2026  (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) (&#34;QTREX&#34; or the &#34;Company&#34;) a company focused on advancing Additively Manufactured Electronics (&#34;AME&#34;) for

QTEX

QTREX Announces Clarification to Registration Statement on Form F-1

QTREX clarifies F-1 filing not for new equity; AME pivot advances

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Ness Ziona, Israel, July  22, 2026  (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) (&amp;#34;QTREX&amp;#34; or the &amp;#34;Company&amp;#34;) a company focused on advancing Additively Manufactured Electronics (&amp;#34;AME&amp;#34;) for</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>QTREX clarified that its Form F-1 resale filing was not a new equity issue, aligning with pre-existing warrant obligations. The company announced a pivot to AME-based quantum tech leveraging Nano Dimension’s technology and disclosed a $10 million common-share raise at $1.50 per share from a leading hedge fund. No cash proceeds are expected unless warrants are exercised, framing near-term risk as modest while highlighting upside from the AME pivot.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>QTREX says the F-1 filing isn&#039;t a new share issue.</li><li>Filing tied to Feb 5, 2026 warrants; pivot to Nano Dimension AME tech.</li><li>$10M raise via common shares at $1.50; no warrants issued in that deal.</li><li>Proceeds only from warrant exercise; no active primary offering.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>QTREX Quantum Ltd (QTEX)</strong>: Clarifies F-1 filing and confirms AME pivot; warrants outstanding may drive future dilution on exercise.</li><li><strong>Nano Dimension Ltd (NNDM)</strong>: Provided AME technology enabling QTREX pivot; potential future collaboration or licensing implications.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. The filing clarification and the AME pivot represent material corporate actions and strategic direction shifts that can influence QTEX’s valuation and investor focus.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>No new primary offering; F-1 clarification reduces near-term dilution risk.</li><li>$10M common-share raise at $1.50 per share; no warrants issued in that deal.</li><li>AME pivot with Nano Dimension tech could support longer-term growth thesis.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date and location: July 22, 2026, Ness Ziona, Israel.</li><li>Registration Statement: Form F-1 filed July 21, 2026 with the SEC.</li><li>Purpose: not a new issuance; relates to outstanding warrants from Feb 5, 2026.</li><li>AME pivot: technology purchased from Nano Dimension Ltd.</li><li>$10 million raised via common shares at $1.50 per share; no warrants in that deal.</li><li>No proceeds to QTREX unless warrants are exercised.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral near-term; AME pivot and warrant activity could add upside later.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">Ness Ziona, Israel, July  22, 2026  (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/QTEX">QTEX</a>) (&#34;QTREX&#34; or the &#34;Company&#34;) a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, made an clarification regarding its recent filing of a resale registration statement on Form F-1 (the "Registration Statement"), which was filed on July 21, 2026 with the U.S. Securities and Exchange Commission (the "SEC"). QTREX wishes to clarify that the purpose of filing the Registration Statement was not for a new issuance of ordinary shares by the Company and not part of a new capital raise.</p>  <p align="justify">For the avoidance of doubt, the Company wishes to clarify that the filing of the Registration Statement was made solely pursuant to the Company’s pre-existing contractual obligations regarding outstanding warrants issued pursuant to a securities purchase agreement dated February 5, 2026.</p>  <p align="justify">Moreover, since then, the Company pivoted its business to Quantum Computing based on the innovative AME technology purchased from Nano Dimension Ltd and raised an additional $10 million USD in a deal that consisted of common shares only at $1.5 per share (no warrants) from a leading hedge fund. The Registration Statement does not constitute a new capital raise, an active primary offering, or the issuance of new securities by the Company, and no proceeds will be received by the Company in connection herewith, except for proceeds which may be received upon exercise of the ordinary share purchase warrants, as disclosed in the Registration Statement.</p>  <p align="justify">This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</p>  <p align="justify"><b>About QTREX Quantum</b><br></br>QTREX Quantum Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/QTEX">QTEX</a>) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business. <br></br>For more information, please visit: <a href="https://www.globenewswire.com/Tracker?data=DTmDo_DPkshlUoUzVhtcesO_wiT-OyaDWQ7RXT9uOK1AcsqbeIvW86GvAz6FzPkH_ThfMqx2VGffE-xTzwmBMQ==" rel="nofollow" target="_blank">www.q-trex.com</a></p>  <p align="justify"><b>Forward-Looking Statement Disclaimer</b><br></br>This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses any proceeds that the Company may receive upon the exercise of the Ordinary Share Purchase Warrants and the use of such proceeds, any dilution that may be caused to existing security holders, the Company’s ability to cause the Registration Statement to be declared effective by the SEC, and the Company’s ability to maintain the effectiveness of the Registration Statement. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under "Risk Factors" in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC.</p>  <p><b>Company Contact</b><br></br>QTREX Quantum<br></br>Email: <a href="https://www.globenewswire.com/Tracker?data=xVmFZglq-PyxMjaNIUgMavW1ZS_iDI5EJEwAk48_geRvjCpEVfZmEvmnpxZGKGG1As0lYTfenLm9D6rVYrel_w==" rel="nofollow" target="_blank">info@q-trex.com</a><br></br>Phone: +972-9-9664485</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc2NjQ0NyM3NzE4NDYzIzIyMTEwMjk="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/YjA1ZDc3NmYtNDQ5Yy00ODI4LThmNTQtMDFlZmNlNGMzYjU1LTEyMjI1ODItMjAyNi0wNy0yMi1lbg==/tiny/QTREX-Quantum-Ltd-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/418aae9b-ab46-4b61-a649-88b2eef4fc28"><img src="https://ml.globenewswire.com/media/418aae9b-ab46-4b61-a649-88b2eef4fc28/small/72a8c93a11446a0369bf7fb191b9562d-png.png" border="0" width="150" height="37" alt="Primary Logo"></img></a></p>

QTREX clarified that its Form F-1 resale filing was not a new equity issue, aligning with pre-existing warrant obligations. The company announced a pivot to AME-based quantum tech leveraging Nano Dimension’s technology and disclosed a $10 million common-share raise at $1.50 per share from a leading hedge fund. No cash proceeds are expected unless warrants are exercised, framing near-term risk as modest while highlighting upside from the AME pivot.

News insight

QTREX Announces Clarification to Registration Statement on Form F-1

AI summary

Sentiment rationale

Key facts

Corporate Developments